[ad_1]
Yakult Danone India, the company behind the probiotic drink Yakult has appointed Hiroshi Hamada as managing director of the firm starting April. Hamada took charge from Minoru Shimada who had led the company for over 10 years.
Hamada will be based in New Delhi at Yakult India’s head office where he will be leading the business operations for the Indian market. With more than 33 years of experience in the corporate world, Hamada has had a career in different verticals, which include accounts, corporate planning, sales and marketing. It said that he will lead the company into the next phase of growth.
During his tenure at Yakult Honsha, the parent company located in Japan, Hamada was instrumental in the establishment of the Yakult European Research Institute in Belgium and played a critical role in joint clinical trials with National Institute of Cholera and Enteric Diseases (NICED), Kolkata.
He also played a pivotal role in building an effective home delivery business model in Yakult Indonesia, before moving to Yakult Malaysia as marketing director. His insights in marketing for 8 long years led him to take reins of the Malaysian market as managing director for six years. Today Yakult Malaysia sells over 350,000 Yakult bottles per day, it added.
Speaking on his new role, Hamada said, “Probiotics is not new to India, but we continue to engage, propagate and educate the health benefits of the unique probiotic bacteria, lactobacillus casei strain Shirota (LcS) in our product which is scientifically validated to improve intestinal health and build immunity. My personal motto is not to give up and face challenges with grit and perseverance. India offers immense opportunities for us by its vast consumer base and its diverse geography. While the pandemic is not yet over, it is pertinent to take care of your health and live a wholesome and active life. We stand committed to good health, the probiotic way. I am excited to deliver this promise to consumers through our signature drink and improve their intestinal health for a better and more productive life.”
According to one study, India’s probiotics market reached a value of ₹2.6 billion in 2021. IMARC Group, a research firm, expects this market to reach ₹7.7 billion by 2027.
[ad_2]
Source link